NASDAQ$XBIT

XBiotech Inc · Q1 2019 earnings

Q1 2019 earnings · · Investor relations

Headline financials

EPS (adj)

-$0.16

Previous: -$0.11-45.5%
Capital Expenditures

$6K

No prior period
Free Cash Flow

-$4.68M

No prior period
Net Income

-$5.86M

Previous: -$4.07M-44.1%
Operating Income

-$5.81M

Previous: -$4.15M-39.9%
Cash & Equivalents

$12M

No prior period
Total Assets

$39.8M

No prior period
Stock-Based Comp

$570K

No prior period

Revenue & EPS history

XBiotech · Revenue · Quarterly

$0

Q4 2025

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2019

Historical avgQ1 2019

+0.3%

Avg return

Earnings day

+0.7%

Avg return

5 days after

+2.3%

Avg return

30 days after

44%

19 / 43 earnings

Positive

+13.5%

Q1 2016

Best reaction

-11.2%

Q1 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025-2.6%
Q3 2025-5.8%-16.0%-18.4%
Q2 2025+5.7%+7.7%-7.4%
Q1 2025-1.7%-3.4%-5.4%
Q4 2024+4.5%-4.8%-7.1%
Q3 2024-1.7%-5.9%-2.0%
Q2 2024-2.4%-7.9%-1.8%
Q4 2023+4.2%+12.6%+45.4%
Q3 2023-0.4%-3.7%+5.4%
Q2 2023-3.0%-4.3%-5.1%
Q1 2023+2.4%+1.8%+66.2%
Q4 2022+4.9%+1.5%+9.2%
Q3 2022-1.4%+1.1%-9.9%
Q2 2022-1.6%-1.4%-20.0%
Q1 2022-5.0%-9.6%-7.5%
Q4 2021+2.0%+6.8%-7.1%
Q3 2021-4.2%-7.3%-25.2%
Q2 2021+1.4%-1.3%-3.0%
Q1 2021+2.8%+0.1%+0.3%
Q4 2020-3.1%-2.5%-14.9%
Q3 2020+5.1%+5.3%-1.1%
Q2 2020+6.8%+14.4%+29.6%
Q1 2020+0.9%-9.3%-10.0%
Q4 2019-1.2%-7.8%+32.2%
Q3 2019+2.9%+12.6%+77.6%
Q2 2019-0.7%+7.1%+22.0%
Q1 2019+3.3%-2.6%-17.9%
Q4 2018-4.6%+10.3%-5.0%
Q3 2018-0.5%+3.7%+17.3%
Q2 2018+3.5%+9.7%-10.7%
Q1 2018+0.0%+3.3%+1.9%
Q4 2017+6.7%+5.1%+9.4%
Q3 2017+2.0%-0.2%+16.5%
Q2 2017-5.0%+4.1%+14.4%
Q1 2017-11.2%-10.7%-68.2%
Q4 2016+6.5%+10.0%+3.2%
Q3 2016+10.3%+9.1%-6.7%
Q2 2016-5.6%-2.2%-9.7%
Q1 2016+13.5%
Q4 2015-6.1%
Q3 2015-7.0%
Q2 2015-1.0%
Q1 2015-1.5%
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro